Zofla 6mg Tablet DEFLAZACORT
Introduction to Zofla 6mg Tablet
Zofla 6mg Tablet is a medication primarily used to treat a condition known as Duchenne muscular dystrophy (DMD) in children aged 5 and older. This condition leads to muscle weakening, and Zofla helps manage its symptoms.
Composition of Zofla 6mg Tablet
The active ingredient in Zofla 6mg Tablet is Deflazacort. This component is crucial for its therapeutic effects, helping to reduce inflammation and suppress the immune system.
Uses of Zofla 6mg Tablet
- Management of Duchenne muscular dystrophy (DMD) in children.
- Reduction of inflammation in various conditions.
- Suppression of the immune system to prevent unwanted immune responses.
Side effects of Zofla 6mg Tablet
Common side effects:
- Weight gain
- Increased appetite
- Round face (Cushingoid appearance)
- Upper respiratory infections (common cold)
- Frequent urination
- Nose and throat inflammation
- Excessive hair growth
- Irritability
Serious side effects:
- Allergic reactions such as rash, itching, or swelling
- Severe dizziness
- Trouble breathing
Precautions of Zofla 6mg Tablet
Before taking Zofla 6mg Tablet, inform your doctor if you are allergic to it or any of its ingredients. Use it with caution during pregnancy and breastfeeding. Do not stop taking Zofla suddenly, as it can lead to steroid withdrawal syndrome, causing symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.
How to Take Zofla 6mg Tablet
- Take Zofla 6mg Tablet once daily by mouth.
- The recommended dose is about 0.9 mg for each kilogram of body weight.
- It can be taken with or without food.
- Avoid taking it with grapefruit juice.
Conclusion of Zofla 6mg Tablet
Zofla 6mg Tablet is an effective medication for managing Duchenne muscular dystrophy in children. It helps reduce inflammation and suppresses the immune system. However, it is essential to follow the prescribed dosage and take necessary precautions to avoid potential side effects. Always consult your healthcare provider for personalized advice.





